Clarity Pharmaceuticals Ltd. (AU:CU6) has released an update.
Clarity Pharmaceuticals Ltd. has announced the successful closure of its $121 million capital raising initiative, with the retail component contributing approximately $10.8 million. The funds will bolster the company’s balance sheet, allowing for the advancement of its innovative radiopharmaceuticals portfolio aimed at improving cancer treatments. The newly issued shares from the retail offering are expected to commence trading by the end of April 2024.
For further insights into AU:CU6 stock, check out TipRanks’ Stock Analysis page.
